Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial.
published in: Human Vaccines & Immunotherapeutics
date of publication: 2016-12-01
main subject: teenager
Cites articles 29
Date
Title
Article - wd:Q37561432